The British Society for Immunology was pleased collaborate with the COV-AD (COVID infection in patient with antibody deficiency) study, the UK Primary Immunodefiniciency Network and Immunodeficiency UK to hold this free public webinar:
'Living with immunodeficiency, living with COVID-19'.
About this webinar
People with immunodeficiency are particularly vulnerable to infection with SARS-CoV-2, are more likely to get very unwell with COVID-19 and don't respond as well to vaccination. Join our panel of experts to hear about the cutting-edge research to understand the immune response after infection and vaccination in people with immune deficiency. What can we do in future to protect this group of people and what are the treatment options? What is the patient perspective and how can lived experience be meaningfully involved in immunology research?
Margaret Bennett, Patient representative, Immunodeficiency UK
Professor Siobhan Burns, University College London
Professor Alex Richter, University of Birmingham
Professor Sinisa Savic, University of Leeds
Dr Doug Brown, British Society for Immunology
Please note, information in the webinar was correct as of 10 March 2022 when the webinar took place. This webinar took place before Evusheld was approved by the MHRA to prevent COVID-19 in people whose immune response is poor. Evusheld was approved in the UK on 17 March 2022.